Medicine

Niacin, meals intake and cardiovascular impacts

.Nature Medicine, Posted online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meals cons...

Opportunities and also challenges for patient-reported outcome evaluation in multimorbidity investigation and strategy

.Contending rate of interests.S.E.H. gets funding from the National Principle of Wellness and also T...

Hibernation science utilized to handle obesity and tweak metabolism

.Attributes Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy understa...

CAR- T and mobile genetics therapies are actually too expensive

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of...

The WHO genomics program of help fair application of human genomics for global health

.The publication of the initial draft of the human genome series in 20011 was actually complied with...

A time-stratified, case\u00e2 $ \"crossover research of heat energy direct exposure and also perinatal death coming from 16 health centers in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, we noted evide...

Advancing global antibiotic study, advancement and gain access to #.\n\nMurray, C. J. L. et cetera. Global trouble of bacterial antimicrobial resistance in 2019: a step-by-step study. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards particular dedications and also activity in the action to antimicrobial resistance. Global Frontrunners Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Health And Wellness Organization. WHO publishes checklist of microorganisms for which brand-new antibiotics are quickly needed to have. Planet Wellness Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Company. WHO bacterial top priority virus checklist, 2024: bacterial virus of hygienics value to lead investigation, progression and strategies to avoid and manage antimicrobial protection. Globe Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entrance. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Health And Wellness Organization. 2023 anti-bacterial representatives in scientific as well as preclinical progression: a guide as well as analysis. World Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Assessment. May 19, 2016 \u00e2 $\" Tackling drug-resistant diseases around the globe: final document as well as recommendations. Evaluation on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB results: documents and also rundown. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Breaking through the wall: an ask for concerted activity on antibiotics research and development. Boston Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: Exactly how can the EU support maintainable advancement and also accessibility to helpful antibiotics? plan possibilities for existing and brand-new medications. International Observatory on Health Equipments as well as Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic use and resistance\u00e2 $\" proving the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Wellness Organization. 2021 AWaRe category. That gain access to, watch, book, classification of anti-biotics for evaluation as well as surveillance of making use of. Planet Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Center for Ailment Avoidance and also Control. Antimicrobial resistance targets: how can our company reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Wellness Association. Absence of development readied to undermine antibiotic efficiency as well as health gains. Planet Wellness Association https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Just how antimicrobial protection is linked to temperature adjustment: a summary of 2 linked international challenges. Int. J. Environ. Res. Public Health twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial diseases: our team require urgent action as well as financial investment that pay attention to the weakest link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Organization. Immunization insurance coverage. Globe Wellness Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection avoidance as well as command in low-resource setups: the need for the local area, the contextual and the practical. Contaminate. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Difficulties of implementing antimicrobial stewardship tools in reduced to center income countries (LMICs). Corrupt. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief past history of the antibiotic era: sessions knew and also challenges for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Client get access to in 14 high-income nations to new antibacterials authorized by the US Fda, European Medicines Firm, Japanese Pharmaceuticals and Medical Gadget Company, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Organization. 2021 antibacterial agents in professional as well as preclinical advancement: a review as well as evaluation. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the business economics must assist the science. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of innovation in antibacterial rehabs. Medical Development Association https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Evaluating specialist utilization of next-generation anti-biotics against insusceptible Gram-negative contaminations in U.S. health centers: a retrospective pal research study. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of technology in anti-bacterial therapies. Medical Innovation Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical assessment and also crucial assessment of motivation approaches for revelation and progression of unfamiliar anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nWellness Unexpected Emergency Readiness and Feedback Authority. R &amp d of medical countermeasures. International Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft plan for an European collaboration under Horizon Europe One Health And Wellness Antimicrobial Protection. European Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic Experimentation Alliance. Entasis Rehabs and also the Worldwide Prescription Antibiotic Research &amp Development Relationship to establish a new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of market- as well as non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health Institution. Variety of medical trial registrations through location, disease, stage of advancement, grow older as well as sex of trial attendees (1999\u00e2 $ \"2022). Globe Wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Prescription Antibiotic Experimentation Relationship. NeoSept1: a study to identify the rank of existing as well as brand-new anti-biotics combos to manage newborn babies that remain in health center along with severe sepsis. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Firm of Canada. Government of Canada makes vital financial investment to combat antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Antibiotic Experimentation Collaboration. Japan government financing sustains GARDP\u00e2 $ s attempts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Base. Novo Nordisk Foundation partners with CARB-X to eliminate drug-resistant infections. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health And Wellness and Digital Exec Company. Research study on carrying AMR clinical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the proper dimension of international pull motivations for anti-bacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry incentive for the progression of brand new anti-biotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Field incentives and also antibiotic protection: an intro to the antibiotic susceptibility bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An enthusiastic USG evolved dedication for subscription-based purchasing of unfamiliar antimicrobials and also its anticipated return on investment. Facility for Global Development https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in brand-new anti-biotics would certainly settle \u00e2 $\" for every person. Office of Health and wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts battle against life-threatening diseases complying with prosperous world-first aviator. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. European Percentage https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Reimbursement versions to attack market breakdowns for antimicrobials: strategies absorbed France, Germany, Sweden, the UK, as well as the USA. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers as well as Organizations. From resistance to strength: what could the potential antibiotic pipe seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Hub &amp Planet Health And Wellness Institution. Incentivising the advancement of brand new anti-bacterial procedures: 2023 progress report due to the Global AMR R&ampD Hub and also That. Worldwide AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Performer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK membership design for prescription antibiotics looked at productive? Lancet Microbe 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimuli for the advancement and also keeping on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and nationwide reasons for child mortality in 2000\u00e2 $ \"13, along with estimates to educate post-2015 priorities: an improved organized analysis. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medicine shortages coming from 2001 to 2013: implications for clinical application. Clin. Infect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French coverage system for drug scarcities: explanation as well as patterns coming from 2012 to 2018: an observational retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Assessment of that antibiotic intake as well as access targets in 76 countries, 2000\u00e2 $ \"15: a study of pharmaceutical purchases records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Battling the fakes: handling low-grade as well as falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving easier to secure anti-biotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Society for Research Laboratory Medicine. Policy brief and also infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic intake for individual usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial usage: study of central storage facilities supplies to in-patient treatment health amenities coming from 2017 to 2019 in Uganda. Trop. Med. Corrupt. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et al. Variations in the consumption of antimicrobial medications in the International area, 2014\u00e2 $ \"2018: findings and also ramifications coming from ESAC-Net as well as That Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Drug lack: reasons, influence, and also mitigation tactics. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual access in 14 high-income nations to new antibacterials accepted by the US Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Equipment Firm, or Health Canada, 2010\u00e2 $ \"2020. Clin. Infect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost antibiotics: a follow-up stock study in Europe, the USA, Canada and Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness innovation for global health. Br. Medication. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Field Partnership. The 2023 AMR Industry Alliance progress questionnaire: production and the atmosphere. amr Industry Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can medical items be created on a charitable manner? Looking into product advancement relationships for ignored illness. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the worldwide public enthusiasm. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Ailment Management and also Prevention. Africa CDC initiates daring relocate to protect Africa\u00e2 $ s health future by producing a 50 billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health patent licensing deals to improve access to health modern technologies: an insider\u00e2 $ s story. BMJ Chunk. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business styles for r &amp d with affordability criteria are needed to accomplish fair costs of medicines. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Gas. Stewardship and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Anti-biotic Research and Development Relationship. Shinogi, GARDP and also CHAI introduce spots certificate as well as cooperation deals to manage microbial contaminations next to increasing access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Partnership. Leaving the lab: tracking the downtrend in AMR R&ampD specialists. amr Market Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 phone call to action on antimicrobial resistance. G7G20 Records Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Union on Aging &amp Contagious Conditions Society of United States. 2024 AMR readiness mark progress report. Determining federal government activity on AMR plan. International Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Meals and Farming Organization of the United Nations, United Nations Atmosphere Program, World Wellness Institution &amp. Planet Company for Pet Health And Wellness. Global data source for tracking antimicrobial resistance (AMR): nation self-assessment questionnaire (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Van Katwyk, S. R. &amp Outterson K. Overview: AMR belongs in the glob...

Integrating liver endpoints in clinical trials of cardio as well as renal ailment

.Nature Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial intellect helped screening for cardiomyopathies in an obstetric populace: a practical randomized clinical test

.Test concept and oversightThe Screening for PEripartum Cardiomyopathies with Artificial Intelligenc...